-- 杰富瑞在4月24日的一份报告中指出,福特斯克(ASX:FMG)季度业绩疲软,同时铁桥项目持续面临挑战,且在非核心绿色能源项目上的支出增加,引发了人们对其回报和估值的担忧。 受季节性和天气因素影响,该公司本季度业绩下滑。尽管皮尔巴拉赤铁矿业务表现稳健,但铁桥磁铁矿项目持续低迷,抵消了部分业绩。铁桥磁铁矿项目持续面临产能和利润率方面的挑战,其估值可能难以支撑。 杰富瑞指出,该公司斥资6.8亿美元用于为工业用户和数据中心等第三方客户建设绿色能源产能,这代表着一项战略转变,但杰富瑞认为这是非核心资本配置,在回报明朗之前,其矿业业务可能需要更高的折现率。 这家股票研究公司表示,该公司位于皮尔巴拉的矿区港口吞吐能力已接近极限,这是一个“好消息”,因为随着公司重新评估其产品组合、削减铁桥矿产量并维持整体出货量预期基本不变,利润更高的赤铁矿生产可能会取代成本更高的铁桥矿产量。 该研究公司补充道,尽管支付了股息并进行了资本支出,但该公司财务状况依然稳健,拥有42亿美元的现金储备,预计长期来看将恢复净现金状态。但该公司也强调了铁桥矿的不确定性以及绿色能源支出增加等风险,包括潜在的资产减值,因此其前景持谨慎态度。 杰富瑞维持对福特斯克的“弱于大盘”评级,并将目标价从17.50澳元下调至16.50澳元。
Related Articles
Stifel Canada Hikes Aritzia Price Target to $158.00
Stifel Canada is expecting another strong quarter from Aritzia (ATZ.TO) when it reports its fiscal fourth-quarter earnings on May 7.Analyst Martin Landry, who is raising his price target on the company's shares by $8.00 to $158.00 and maintaining a buy rating, is also hiking comparable sales growth expectation by 700bps to 21% Y/Y, higher than consensus of 18%."We expect Aritzia to introduce a FY27 guidance higher than current consensus expectations, potentially driving upwards earnings revisions," Landry adds. Aritzia shares touched an all-time high on Friday as investors are pricing the company's strong operational performance.Landry also expects earnings per share growth of 34% Y/Y in fiscal 27, higher than peers.Price: $139.87, Change: $-3.34, Percent Change: -2.33%
HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says
HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%
BluEnergies Announces DTC Eligibility
BluEnergies (BLU.V) shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company (DTC), BluEnergies said on Monday.The company's shares recently began trading on the OTCQX Best Market under the ticker BLUGF, it added."Obtaining DTC eligibility marks an important step in expanding BLU's investor base and enhancing accessibility for shareholders," said chief executive Craig Steinke. "For investors, DTC eligibility is a key milestone that streamlines electronic trading and supports improved liquidity, which is especially important as we advance the development of our assets in the Harper Basin, Liberia and Gulf of America and continue to build long-term value across our portfolio."The company's shares were last seen down $0.09, or 3.1%, to $2.73 on the TSX Venture Exchange.Price: $2.73, Change: $-0.09, Percent Change: -3.19%